Preferred Pharmaceuticals Fexofenadine HCl Tablets Recall

Why it was recalled

Failed Impurities/Degradation Specifications

Product description

Fexofenadine HCl Tablets, 180 mg, Pkg Size 90, Mfg: Aurohealth LLC, Repackaged by Preferred Pharmaceuticals, Inc., Anaheim, CA, NDC #: 68788-6848-09

Lot numbers, UPCs & expiration codes

Lot #: G0219K, Exp 3/2021; C1419E, Exp 3/2021

Where it was sold

Product was distributed to 1 physician in Gainesville Florida.

What to do if you have this product

Compare the lot number and expiration date on your package with the codes above.
Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
If you have symptoms you think are related, contact your doctor. In an emergency call 911.
Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number: D-1877-2019
Classification: Class II
Status: Terminated
Recall initiated: Aug 29, 2019
FDA report date: Oct 2, 2019
Quantity: 79 (90 ct.) bottles
Recall type: Voluntary: Firm initiated
Recalling firm: Preferred Pharmaceuticals, Inc

Original FDA data

Every field from FDA enforcement report D-1877-2019, exactly as published.

Show all FDA fields

City: Anaheim
State: CA
Status: Terminated
Country: United States
Event ID: 83711
Address: 1250 N Lakeview Ave Ste O
Code information: Lot #: G0219K, Exp 3/2021; C1419E, Exp 3/2021
Postal code: 92807-1801
Report date: Oct 2, 2019
Product type: Drugs
Recall number: D-1877-2019
Classification: Class II
Recalling firm: Preferred Pharmaceuticals, Inc
Product quantity: 79 (90 ct.) bottles
Termination date: Apr 24, 2023
Reason for recall: Failed Impurities/Degradation Specifications
Voluntary / mandated: Voluntary: Firm initiated
Product description: Fexofenadine HCl Tablets, 180 mg, Pkg Size 90, Mfg: Aurohealth LLC, Repackaged by Preferred Pharmaceuticals, Inc., Anaheim, CA, NDC #: 68788-6848-09
Distribution pattern: Product was distributed to 1 physician in Gainesville Florida.
Recall initiation date: Aug 29, 2019
Initial firm notification: Telephone
Center classification date: Sep 24, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1877-2019, published Oct 2, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: Oct 2, 2026. Content last changed: Oct 2, 2026.

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.